Empress Therapeutics
PrivateLast Round
Series A
Jun 21, 2023
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Empress Therapeutics operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series A round in June 2023.
Empress Therapeutics is a biotechnology company that develops small-molecule drug candidates by leveraging its proprietary Chemilogics platform, which integrates genetic data, artificial intelligence, and synthetic biology to identify drug starting points from the human body.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Empress Therapeutics Comparables
Compare Empress Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesalius Therapeutics | 86% | |
| LifeMine Therapeutics | 82% | |
| Hexagon Bio | 80% |
For institutional investors. Book with your work email.
Empress Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Empress Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 565% MoM, reaching 1.2K.
- Jun 21, 2023
$50M round led by Flagship Pioneering
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- decreases_headcount_byOct 29, 2026
Empresstx decreases its headcount by 23 employees through layoffs in Mar '25, representing about half its staff at the time.
For institutional investors. Book with your work email.
Empress Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Empress Therapeutics's valuation, stock price, and market status.
Is Empress Therapeutics a public or private company?
Empress Therapeutics is a private company.
What is the current stock price of Empress Therapeutics?
Empress Therapeutics is a private company, so its shares have no public market price. Caplight tracks Empress Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Empress Therapeutics worth (valuation)?
Valuation information for Empress Therapeutics is not publicly available.
Can I buy Empress Therapeutics stock?
Empress Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Empress Therapeutics's last funding round?
Empress Therapeutics's most recent funding round was Series A on June 21, 2023.
Who are the main investors in Empress Therapeutics?
Key investors in Empress Therapeutics include Flagship Pioneering.
Will Empress Therapeutics IPO soon?
No public IPO plans have been announced for Empress Therapeutics.
How can I track Empress Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Empress Therapeutics's shares on secondary markets.